M-tron Industries, Inc.
M-tron Industries, Inc. Q3 FY2026 earnings call
November 12, 2026 · fiscal period ended 2026-09
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2026-11-12
Management highlights
- Strong Defense Demand: Revenue growth is primarily driven by aerospace and defense orders, particularly in radar and electronic warfare systems, which grew over 100%. The company is a key supplier to precision-guided ammunition programs under multi-year framework agreements.
- Backlog and Book-to-Bill: Backlog remains strong with a book-to-bill ratio slightly above one. Management anticipates large orders originally expected in Q3/Q4 2026 will close early in the new year, causing a temporary backlog dip in Q4 followed by strengthening in Q1 2027.
- Manufacturing Expansion: The company is actively expanding capacity, including hiring and CapEx investments. A transaction to expand the Orlando plant is underway, though management notes that if purchase order volumes meet high-end press expectations, a new facility may be required by 2029-2030.
- Strategic Inorganic Growth: Imtron is executing a three-pronged inorganic strategy acting as a holding company, vehicle for carve-outs/mergers, and investment platform. They have hired corporate development staff and are pursuing an RF product acquisition likely to be announced before year-end.
- Market Resilience: Management is not alarmed by Boeing’s recent workforce reduction, noting it aligns with slower airframe delivery ramps and does not impact Imtron’s near-term results or 2027 growth trajectory.
Segment performance
The transcript does not provide a breakdown of financial performance by specific product segment (e.g., Radar, Electronic Warfare). It reports consolidated Total Revenues of $15.7 million for Q3 2026, an 11.1% increase from $14.2 million in Q3 2025. Gross margin was 44.5%, with gross profit at $7 million. Net income was $3 million ($0.70 per diluted share), and Adjusted EBITDA was $3.6 million.
Guidance
- Revenue Growth: Expects to end FY2026 with year-over-year revenue growth around 13% (consistent with YTD performance).
- FY2027 Outlook: Anticipates acceleration in growth rates for FY2027 compared to FY2026.
- FY2028 Outlook: Forecasts growth rates in the 'high-teens' percentage range for FY2028, driven by significant increases in order quantities for missile replenishment programs.
- Gross Margin: Targets a gross margin range of 43% to 46% for the coming year. While current quarter margins were boosted by favorable product mix, management expects slight pressure next year due to scaling costs (hiring/capex) but believes long-term rates can be maintained or increased slightly.
Risks
- Federal Budget Uncertainty: The FY27 federal defense budget is not yet signed, creating visibility challenges, though framework agreements provide some forward visibility.
- Lumpy Bookings: Order timing is subject to political environments in Washington; delays in contract awards can shift revenue recognition into future quarters.
- Execution Risk on Expansion: High CapEx requirements (~$4 million this year, ~78% of revenue) are necessary to meet demand. Failure to scale production efficiently could impact margins.
- Customer Concentration/Risk: Reliance on major prime contractors like Raytheon and Lockheed Martin; while diversified across multiple missile systems, disruptions in these large programs could impact volume.
Q&A highlights
Q: Analyst asks if revenue growth will accelerate in 2028 given the anticipated backlog growth in 2027. / A: CEO confirms strong current demand, stating backlog exceeds quarterly production capacity. He projects FY2026 growth to end near 13%, accelerating in FY2027, and reaching the 'high-teens' percentage range in FY2028 due to missile replenishment contracts.
Q: Analyst inquires about the sustainability of high gross margins and the impact of upcoming growth investments. / A: CEO explains that previous headwinds from scaling new products have improved. He forecasts FY2027 gross margins between 43-46%, noting a potential slight dip due to hiring and CapEx investments needed to scale production, but maintains confidence in maintaining or slightly increasing long-term rates.
Q: Analyst seeks details on defense programs bidding on and the impact of the uncertain defense budget. / A: CEO highlights that despite budget flux, over $100 billion in missile contracts were awarded in September, mostly five-year agreements. He anticipates winning fair share of bids for newer, cost-effective vendors and expects Purchase Orders to materialize early in the new year post-Congress seating, providing significant visibility.
Q: Analyst asks about the corporate development strategy and proximity of deals. / A: CEO reveals they have one RF product deal aimed for announcement before year-end. They are also evaluating larger RF companies and systems-oriented spin-outs, leveraging their platform for A&D acquisitions to broaden their market reach.
Q: Analyst questions CapEx trends and whether a new facility will be needed beyond the Orlando expansion. / A: CEO states FY2026 CapEx was elevated (>78% of revenue) for new production lines. While Orlando expansion is underway, he warns that if PO volumes match high-end press discussions, a second facility (Orlando or elsewhere) may be required by 2029-2030 to meet demand.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | — | — | — | — |
| Revenue | — | — | — | — |
Transcript
November 12, 2026Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.